BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22050849)

  • 1. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
    Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
    Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of multiplexed assay systems for molecular diagnostics.
    Schwarz E; VanBeveren NJ; Guest PC; Izmailov R; Bahn S
    Int Rev Neurobiol; 2011; 101():259-78. PubMed ID: 22050855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of introducing new biomarker products for neuropsychiatric disorders into the market.
    Bahn S; Noll R; Barnes A; Schwarz E; Guest PC
    Int Rev Neurobiol; 2011; 101():299-327. PubMed ID: 22050857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
    Lowe CR
    Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
    Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
    J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward personalized medicine in the neuropsychiatric field.
    Wong EH; Fox JC; Ng MY; Lee CM
    Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery.
    Thongboonkerd V
    Expert Rev Proteomics; 2005 Jun; 2(3):349-66. PubMed ID: 16000082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic research in psychiatry.
    Taurines R; Dudley E; Grassl J; Warnke A; Gerlach M; Coogan AN; Thome J
    J Psychopharmacol; 2011 Feb; 25(2):151-96. PubMed ID: 20142298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches in biological and medical sciences: principles and applications.
    Conrotto P; Souchelnytskyi S
    Exp Oncol; 2008 Sep; 30(3):171-80. PubMed ID: 18806738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of serum biomarkers for major psychiatric disorders.
    van Beveren NJ; Hoogendijk WJ
    Int Rev Neurobiol; 2011; 101():351-74. PubMed ID: 22050859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
    Fang X; Balgley BM; Lee CS
    Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in neurosciences.
    Drabik A; Bierczynska-Krzysik A; Bodzon-Kulakowska A; Suder P; Kotlinska J; Silberring J
    Mass Spectrom Rev; 2007; 26(3):432-50. PubMed ID: 17405153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomic applications of formalin-fixed paraffin-embedded tissues.
    Blonder J; Veenstra TD
    Clin Lab Med; 2009 Mar; 29(1):101-13. PubMed ID: 19389554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.